Metroson 200 mg/5 ml (Oral Suspension)
60 ml bottle: ৳ 18.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Metronidazole |
| Company | Hudson pharmaceuticals ltd |
| Also available as |
Title
Metroson 200 mg/5 ml Suspension
Categories
- Antibiotic
- Antiprotozoal
- Amoebicide
- Anti-diarrheal
Description
Metroson is a medication used for the treatment and prevention of various bacterial and parasitic infections.
Attributes
- Indications:
- Prevention of post-operative infections due to anaerobic bacteria
- Treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis
- Treatment of urogenital trichomoniasis
- Treatment of bacterial vaginosis
- Treatment of amoebiasis and giardiasis
- Treatment of acute ulcerative gingivitis
- Treatment of anaerobically infected leg ulcers and pressure sores
- Treatment of acute dental infections due to anaerobic organisms
- Management of antibiotic-associated pseudomembranous colitis
- Pharmacology: Metroson is a member of the imidazole class of antibacterial drug and is classified therapeutically as an antiprotozoal agent. It interacts with DNA and provides bactericidal action against anaerobic bacteria.
- Dosage & Administration:
- Available in Tablet, Suspension, Vaginal Gel, Suppository, and IV Infusion forms with specific dosages for various indications and age groups
- Interaction:
- Potential interactions with disulfiram, alcohol, oral anticoagulants, lithium, cyclosporin, phenytoin or phenobarbital, 5-fluorouracil, and busulfan
- Contraindications: Contraindicated in patients with a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives
- Side Effects:
- Metallic taste
- Nausea
- Vomiting
- Diarrhoea
- Drowsiness
- Rashes
- Pregnancy & Lactation:
- US FDA Pregnancy Category B
- Excreted in human milk
- Precautions & Warnings:
- Regular monitoring of leucocyte count
- Cautious use in patients with hepatic encephalopathy
- Metroson may darken urine
- Use in Special Populations:
- Hepatic impairment may require reduced daily dosage
- No dosage reduction needed in renal impairment
- Efficient removal during haemodialysis in patients with renal failure undergoing intermittent peritoneal dialysis (IDP) or continuous ambulatory peritoneal dialysis (CAPD)
- Overdose Effects: Symptoms limited to vomiting, ataxia, and slight disorientation
- Therapeutic Class: Amoebicides, Anti-diarrhoeal, and Antiprotozoal
- Storage Conditions: Store below 30°C, protected from light, and out of reach of children
- Commonly Asked Questions:
- Uses of Metroson
- Side effects of Metroson
- Improvement timeline
- Contraindications
- Safety during pregnancy
- Safety in overdose situations
- Quick Tips for using Metroson